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7a,25-dihydroxycholesterol (7a,25-OHC) is a ligand
for the G protein-coupled receptor EBI2; however,
the cellular sources of this oxysterol are undefined.
7a,25-OHC is synthesized from cholesterol by the
stepwise actions of two enzymes, CH25H and
CYP7B1, and is metabolized to a 3-oxo derivative
by HSD3B7. We showed that all three enzymes con-
trol EBI2 ligand concentration in lymphoid tissues.
Lymphoid stromal cells were the main CH25H- and
CYP7B1-expressing cells required for positioning of
B cells, and they also mediated 7a,25-OHC inactiva-
tion. CH25H and CYP7B1 were abundant at the
follicle perimeter, whereas CH25H expression by
follicular dendritic cells was repressed. CYP7B1,
CH25H, and HSD3B7 deficiencies each resulted in
defective T cell-dependent plasma cell responses.
These findings establish that CYP7B1 and HSD3B7,
as well as CH25H, have essential roles in controlling
oxysterol production in lymphoid tissues, and they
suggest that differential enzyme expression in stro-
mal cell subsets establishes 7a,25-OHC gradients
required for B cell responses.
INTRODUCTION
In order to mount a rapid and efficient antibody response, B cells
undergo a series of dynamic movements within secondary
lymphoid organs (Cyster, 2010). Naive B cells express the che-
mokine receptor CXCR5 and are attracted into follicles by this
receptor’s ligand, CXCL13, which is made by stromal cells
distributed throughout the follicle. After encountering antigen,
activated B cells upregulate CCR7 and move within 6 hr to the
B cell zone-T cell zone (B-T) boundary of the follicle in response
to the T zone-expressed CCR7 ligand, CCL21. There, they in-
teract with cognate T helper cells, and subsequently the T cell-
primed B cells downregulate CCR7 and relocate to interfollicular
and outer follicular regions for further clonal expansion prior toImtheir differentiation into short-lived antibody-secreting plasma
cells or germinal center (GC) B cells (Coffey et al., 2009; Cyster,
2010; Kerfoot et al., 2011; Kitano et al., 2011). EBI2, a G protein-
coupled receptor, guides B cell movement along the B-T
boundary and later to interfollicular and outer follicular regions
(Gatto et al., 2009; Gatto et al., 2011; Kelly et al., 2011; Pereira
et al., 2009). The absence of EBI2 from B cells results in their
premature accumulation in the center of the follicle and dimin-
ished T cell-dependent plasma cell differentiation (Gatto et al.,
2009; Pereira et al., 2009).
7a,25-dihydroxycholesterol (7a,25-OHC) was recently identi-
fied by classic analytical methods as a high-affinity ligand for
EBI2 (Hannedouche et al., 2011; Liu et al., 2011). 7a,25-OHC
was previously identified as an intermediate in the alternate
pathway of hepatic bile acid synthesis (Russell, 2003). The
conversion of cholesterol into bile acids is accomplished in
the liver through two multienzyme pathways, commonly referred
to as the classic and alternate pathways of bile acid syn-
thesis. Studies in gene-deficient mice revealed that the
essential requirement for bile acids can be met through either
of the two pathways, and thus that they serve compensatory
roles in hepatic lipid metabolism (Russell, 2003). 7a,25-OHC
is synthesized from cholesterol by CH25H-mediated hydrox-
ylation at the 25 position, followed by CYP7B1-mediated
hydroxylation at the 7a position (Russell, 2003) (Figure 1A).
Unexpectedly for a protein that carries out a reaction related
to bile acid synthesis, CH25H is poorly expressed in the liver
but is abundant in a number of other tissues, suggesting the
enzymemay function outside the liver (Lund et al., 1998; Russell,
2003). Recent studies have shown that CH25H is highly ex-
pressed in activated macrophages (Bauman et al., 2009; Dicz-
falusy et al., 2009; Park and Scott, 2010; Zou et al., 2011).
Genetic deficiency in CH25H has been shown to cause a loss
of EBI2 ligand generation in lymphoid organs (Hannedouche
et al., 2011). Although macrophages are considered the most
likely cells acting in lymphoid tissues to carry out the 25-hydrox-
ylation reaction needed to generate EBI2 ligand (Hannedouche
et al., 2011; Liu et al., 2011), their role in this process was not
tested.
CYP7B1, a member of the cytochrome P450 enzyme family, is
abundant in the liver, but Cyp7b1 transcripts have also been de-
tected in a number of extrahepatic tissues (Stiles et al., 2009). Inmunity 37, 535–548, September 21, 2012 ª2012 Elsevier Inc. 535
Figure 1. CYP7B1 Is Required for EBI2 Ligand Generation and Activated B Cell Positioning
(A) Enzymatic steps catalyzed by CH25H, CYP7B1, and HSD3B7.
(B) Bioassay of titrated dilutions of spleen and LN extracts from Cyp7b1–/– or wild-type animals using a reporter cell line (M12) with or without EBI2 (mean ± SEM,
n = 4 mice).
(C) Bioassay of titrated dilutions of supernatant from 293T cells transfected with the empty vector (hCD4) or vector(s) encoding CH25H, CYP7B1, and CH25H plus
CYP7B1 (co-express), or from a mixture of the individually transfected cells (Sep-express) (mean ± SEM, n = 4 mice from two experiments).
(D) EBI2 surface staining of Ebi2–/– or wild-typeMD4 B cells 10 hr after HEL immunization or 48 hr after HEL-OVA immunization (One experiment representative of
three experiments).
(E) Migration of antigen-specific (MD4) B cells and noncognate B cells from spleens of 10-hr- or 2-day-immunized recipients (as in D) in response to 7a,25-OHC
(mean ± SEM, four mice in each group, one experiment representative of two experiments).
(F andG) Spleen sections were analyzed from the indicatedmice, with (F) or without (G) immune challenge. TransferredMD4B cells were detected byHEL binding
(blue) and endogenous B cells by anti-IgD (brown). Data are representative of at least three independent experiments.
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CYP7B1 and HSD3B7 Establish EBI2 Ligand Gradientsthe kidney, CYP7B1 may contribute to de novo sterol synthesis
(Li-Hawkins et al., 2000), and in the reproductive tract, the
enzyme has a role in metabolizing androgens (Omoto et al.,
2005). In a recent report, treatment with the nonspecific cyto-
chrome P450 inhibitor, clotramizole, reduced 7a,25-OHC in536 Immunity 37, 535–548, September 21, 2012 ª2012 Elsevier Inc.mouse spleen (Liu et al., 2011). This study provides support for
CYP7B1 functioning in 7a,25-OHC generation in the spleen,
but indirect effects of the drug could not be excluded. Moreover,
the cell types involved in 7a,25-OHC generation were not
determined.
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CYP7B1 and HSD3B7 Establish EBI2 Ligand GradientsHydroxylated sterols are furthermetabolized to 3-oxo,D4 inter-
mediates during the process of bile acid synthesis by a micro-
somal 3b-hydroxy-D5-C27 steroid oxidoreductase (HSD3B7)
(Russell, 2003) (Figure 1A). This enzyme catalyzes isomerization
of the double bond from the 5 to the 4 position and the oxidation
of the 3b-hydroxyl to a 3-oxo group (Russell, 2003). HSD3B7 only
acts on C27 sterols with a 7a-hydroxyl group. Loss of HSD3B7
blocks the synthesis of the major biologically active forms of
bile acids, resulting in vitamin deficiency and cholesterol malab-
sorption (Shea et al., 2007). Mice with this defect can by rescued
by addition of a pan-vitamin supplement to the drinking water
and a bile acid (cholic acid) to the diet (Shea et al., 2007). It is
not yet known whether HSD3B7 acts in nonhepatic tissue on
substrates such as 7a,25-OHC, nor whether 7a,25-OHC modifi-
cation by HSD3B7 alters EBI2 ligand activity.
In this study, we have demonstrated that CH25H, CYP7B1,
and HSD3B7 constitute an extrahepatic pathway that regu-
lates oxysterol production in lymphoid tissues. We show that
CH25H and CYP7B1 are abundantly expressed by lymphoid
stromal cells and that they are required in these cells to generate
the 7a,25-OHC-ligand gradient that guides EBI2-mediated B cell
movement. We also found that follicular dendritic cells (FDCs)
are needed to allow EBI2-dependent B cell positioning within
the follicle. Stromal cell HSD3B7 inactivates 7a,25-OHC, and in
the absence of this enzyme, EBI2 ligand abundance is markedly
increased and B cell positioning fails. HSD3B7 also functions in
dendritic cells (DCs) to restrict their EBI2 ligand production.
Consistent with a crucial role in generating EBI2 ligand gradients,
CYP7B1, CH25H, andHSD3B7 deficiencies are each associated
with impaired humoral immune responses.
RESULTS
CYP7B1 Is Required for Generating EBI2 Ligand Activity
As well as being abundant in liver, CYP7B1 transcripts are
present in lymphoid organs (Hannedouche et al., 2011; Li-Haw-
kins et al., 2000; Rose et al., 2001). To investigate whether
CYP7B1 is required for EBI2 ligand generation, we prepared
extracts from lymphoid tissues of CYP7B1-deficient and litter-
mate control mice. CYP7B1-deficient mice rely on the classic
pathway of bile acid biosynthesis but are otherwise healthy
and grow normally (Li-Hawkins et al., 2000; Rose et al., 2001).
EBI2 ligand abundance in lymphoid tissues was assessed with
a bioassay that measures the ability of tissue extracts to induce
the migration of an EBI2-expressing cell line that has subnano-
molar sensitivity for 7a,25-OHC in a transwell assay (Figures
S1A and S1B available online) (Hannedouche et al., 2011; Kelly
et al., 2011). Extracts from Cyp7b1/ spleen and lymph nodes
(LNs) lacked EBI2 ligand activity, whereas extracts from wild-
type littermate control tissues contained readily detectable bio-
activity (Figure 1B). We also tested the sufficiency of CYP7B1
to generate EBI2 ligand in transfected cells. Overexpression
of CYP7B1 in HEK293T cells did not elevate EBI2 ligand gener-
ation, but cotransfection of CH25H and CYP7B1 together
achieved a strong synergistic effect in promoting ligand produc-
tion (Figure 1C). Notably, the synergistic activity of CH25H and
CYP7B1 did not require coexpression in the same cells, because
coculturing cells that were separately overexpressing CH25H
and CYP7B1 generated EBI2 ligand to a similar extent as thatImobserved for cultures of cotransfected cells (Figure 1C). These
observations suggest that 25-OHC can be transferred between
cells to serve as a substrate for CYP7B1, with subsequent
release of 7a,25-OHC into the culture supernatant.
To test whether CYP7B1 is required for EBI2-dependent B cell
movement, we examined naive and activated B cell positioning
in Cyp7b1–/– or littermate control recipients. Previous work has
shown that at day 2 after activation by antigen and T cell interac-
tion, B cells position to interfollicular and outer follicular regions
in an EBI2-dependent manner, and expression of green fluores-
cent protein (GFP) from the Ebi2 locus in EBI2-GFP reporter mice
is elevated (Coffey et al., 2009; Kerfoot et al., 2011; Kitano et al.,
2011; Pereira et al., 2009). Unexpectedly, Ebi2 transcript abun-
dance is reduced in activated B cells at this time point (Gatto
et al., 2009; Kelly et al., 2011). To clarify this situation, we used
a polyclonal antiserum specific for EBI2 to demonstrate that
EBI2 surface abundance was increased early after B cell activa-
tion (Figures 1D and S1). Surface expression remained abundant
at day 2 of the T cell-dependent B cell response, though the
higher background staining on Ebi2–/– B cells at this time
point made it difficult to compare the expression to the earlier
time points (Figure 1D). However, according to in vitro analysis,
7a,25-OHC chemotactic responsiveness of both 10-hr- and
2-day-activated B cells was elevated compared to naive B cells
(Figure 1E). Using a hen egg lysozyme (HEL)-specific MD4
immunoglobulin (Ig)-transgenic B cell plus ovalbumin (OVA)-
specific OTII T cell receptor (TCR)-transgenic T cell adoptive
transfer model that allows in situ tracking of activated B cell
distribution (Kelly et al., 2011), we found that at day 2 after
HEL-OVA immunization, activated B cells in Cyp7b1–/– mice
failed to move to interfollicular and outer follicular regions and
instead were dispersed throughout the follicle (Figure 1F). This
distribution was distinct from that observed for day-2-activated
Ebi2–/– MD4 B cells in wild-type hosts that accumulated near
the follicle center (Figure 1F). We interpret this difference as
being a consequence of the ability of the endogenous B cells
in wild-type hosts to respond to EBI2 ligand, a responsiveness
that allowed them preferential access to the outer follicle com-
pared to the donor EBI2-deficient B cells. Consistent with this
explanation, the presence or absence of EBI2 had no effect on
day-2-activated B cell distribution in CYP7B1-deficient hosts
(Figure 1F). Finally, we examined the distribution of Ebi2–/– naive
B cells in follicles 1 day after transfer, given that these cells also
show a predilection for the follicle center in wild-type hosts
(Gatto et al., 2009; Pereira et al., 2009). Again, we found that
this tendency to accumulate in the central follicle was lost in
Cyp7b1–/– hosts (Figure 1G). Taken together, these findings indi-
cate that CYP7B1 is required for generation of EBI2 ligand within
lymphoid tissues, which in turn is needed for EBI2-dependent
B cell movement to interfollicular and outer follicular regions.
HSD3B7 Inactivates EBI2 Ligand and Is Required
for Normal B Cell Positioning
HSD3B7 is abundant in liver (Schwarz et al., 2000) and ex-
pressed in lower amounts in LNs and spleen (Figure 2A). To
test for a potential role of this enzyme in regulating EBI2-ligand
activity, 7a,25-OHC was incubated in chambers containing
HEK293T cells transfected with a vector encoding Hsd3b7 or
a control vector. Incubation with HSD3B7-expressing cells ledmunity 37, 535–548, September 21, 2012 ª2012 Elsevier Inc. 537
Figure 2. HSD3B7 Degrades EBI2 Ligand and Is Required for Activated B Cell Positioning
(A) Quantitative PCR analysis of HSD3B7 transcript abundance in the indicated tissues or cell preparations, relative to HPRT (mean ± SEM, n = 3 mice). T cells
were defined as CD3+ cells, B cells as CD19+ cells, and DCs as CD11chiMHCII+ cells.
(B) Bioassay measurement of remaining 7a,25-OHC activity following a 6 hr incubation with 293T cells expressing the control (hCD4) vector or HSD3B7 (mean ±
SEM, n = 3 experiments).
(C) Bioassay measurement of EBI2 ligand activity remaining in 10% splenic tissue extract following 6 hr incubation with 293T cells expressing hCD4 or HSD3B7-
hCD4 (mean ± SEM, n = 3 mice).
(D and E) Mice were reconstituted with BM transduced with an HSD3B7-expressing or control (hCD4) vector.
(D) Bioassay of spleen extracts (mean ± SEM, n = 3 mice).
(E) MD4 and OTII splenocytes were transferred into reconstituted mice, and the distribution of MD4 B cells was visualized in the spleen 2 days after HEL-OVA
immunization.
(F) Bioassay of titrated dilutions of spleen extracts from Hsd3b7/ or wild-type animals (mean ± SEM, n = 4 mice).
(G) EBI2 surface expression onM12 cells expressing EBI2-IRES-GFP and splenic B cells, following 35min incubationwith the indicated amounts of 7a,25-OHCor
diluted dimethyl sulfoxide (DMSO) control.
(H) EBI2 surface expression on splenic follicular B cells from Ebi2/, Hsd3b7+/+, and Hsd3b7/ mice.
(I) Spleen sections from the indicated mice 2 days after HEL-OVA immunization. Transferred MD4 B cells were detected by HEL binding (blue) and endogenous
B cells with anti-IgD (brown).
Data in (E)–(I) are each representative of at least three experiments.
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CYP7B1 and HSD3B7 Establish EBI2 Ligand Gradientsto a complete loss of activity in the EBI2 bioassay, suggesting
that isomerization of the double bond and oxidation of the
3b-hydroxyl is sufficient to inactivate receptor binding and ago-
nism (Figure 2B). EBI2 bioactivity in spleen extracts could also
be inactivated by HSD3B7-expressing cells (Figure 2C). As an
initial approach to determine whether HSD3B7 regulated EBI2
ligand abundance in vivo, we reconstituted mice with HSD3B7
or control retroviral vector-transduced bone marrow (BM) cells.
Overexpression of HSD3B7, but not of the control vector, in
BM-derived cells reduced splenic EBI2 bioactivity (Figure 2D)
and disrupted day-2-activated B cell positioning at the outer
follicle (Figure 2E).
Having established that HSD3B7 was sufficient to degrade
EBI2 ligand, we next asked whether this enzyme is necessary
for controlling EBI2 ligand abundance in lymphoid tissues. To
answer this question, we compared EBI2 bioactivity in spleen
and LN extracts of Hsd3b7+/+ and Hsd3b7–/– mice and found
a more than 5-fold elevation in the amount of activity that could
be detected (Figures 2F and S2A). When the tissue extract was
used at high concentration (1 in 2 dilution), migration was dimin-
ished (Figure 2F). A similar loss ofmigration occurred in response
to high concentrations of synthetic 7a,25-OHC (Figure S1B),
probably because of receptor desensitization before cell migra-
tion had taken place. Indeed, exposure of EBI2-transduced cells
and naive B cells to synthetic 7a,25-OHC for 35 min decreased
EBI2 surface expression (Figure 2G). We used the sensitivity
of EBI2 to ligand-mediated downregulation as an additional
approach to investigate whether ligand amounts were increased
in the absence of HSD3B7. Splenic follicular B cells isolated from
Hsd3b7-–/– mice showed reduced surface EBI2 abundance
compared to cells from control mice (Figure 2H), consistent
with the presence of greater amounts of interstitial 7a,25-OHC
in the lymphoid tissue of mice lacking this catabolic enzyme.
Lastly, we assessed EBI2-dependent positioning in Hsd3b7 –/–
mice. At day 2 after HEL-OVA immunization, activated MD4 B
cells did not localize at the outer follicle but instead distributed
evenly throughout the follicle in Hsd3b7 –/– mice (Figure 2I).
Moreover, as observed in CYP7B1-deficient hosts, Ebi2–/– day-
2-activated B cells and Ebi2/ naive B cells failed to show any
preference for the follicle center in HSD3B7-deficient hosts
(Figures 2I and S2B). Together, these results indicate that
HSD3B7 both inactivates 7a,25-OHC and maintains EBI2 ligand
gradients that are crucial for proper B cell movements within
lymphoid tissue.
Differential CH25H and CYP7B1 Expression in Outer
versus Inner Follicle
We next dissected the cellular expression of CH25H, CYP7B1,
and HSD3B7 in lymphoid organs. LN cells were separated into
CD45+ hematopoietic cells and CD45– stromal cells, and, based
on CD31 and gp38 (podoplanin) staining, CD45– stromal cells
were further divided into: gp38+CD31– fibroblastic reticular
cells (FRCs), gp38+CD31+ lymphatic endothelial cells (LECs),
gp38–CD31+ blood endothelial cells (BECs), and gp38–CD31–
double negative (DN) cells (Link et al., 2007) (Figure 3A).
CH25H, CYP7B1, and HSD3B7 expression in CD45– stromal
cells was 10–1,000-fold higher than in CD45+ cells, whereas
EBI2 was enriched in CD45+ cells (Figure 3B). Among stromal
cell populations, FRCs expressed the highest amount ofImCYP7B1 and also had abundant CH25H (Figure 3C), suggesting
this cell type may contribute to EBI2 ligand production. To test
this possibility further, double-sorted CD45– stromal cell popula-
tions were cultured for 1 day, and culture supernatants were
tested for their ability to stimulate EBI2-dependent B cell migra-
tion. Bioactivity was readily detected in FRC cultures (Figure 3D).
The high background response of the control cells to culture
supernatants from the BECs and the gp38–CD31– DN stromal
cells prevented us from assessing ligand production by these
cells. FRCs include stromal cells that are distributed in both
the T zone and follicular regions (Cyster et al., 2000), such
as the so-called marginal reticular cells (MRCs) that are present
in the outer margin of the follicle (Katakai et al., 2008). MRCs
express TRANCE (Tnfsf11), and a high abundance of TRANCE
transcripts in our FRC preparations (Figure 3C) confirmed the
presence of MRCs in these samples.
Currently, there are no markers available for distinguishing
follicular and T zone stromal cells via flow cytometry. In an effort
to compare CH25H expression between these cells, we per-
formed single-cell PCR for the following set of transcripts:
CXCL13, CCL21, CR1-CR2 (using a primer pair common to both
isoforms), CH25H, and HPRT. The success of our single-cell
analysis was confirmed by the finding that most gp38+CD31–
stromal cells expressed either CXCL13 or CCL21, but not
both; the few cells wherein both were detected may correspond
to cell doublets. By this analysis, high CH25H transcript abun-
dance was detected in the majority of CXCL13 and CCL21
single-expressing cells (Figure 3E). The CR1-CR2-expressing
cells were restricted to the CXCL13+ stromal cell subset (Fig-
ure 3E), consistent with their being FDCs. Importantly, the
amounts of CH25H transcript detected in CR1-CR2+ cells
were low compared to the amounts in many of the CXCL13+
CR1-CR2– cells (Figure 3E). To further assess enzyme abun-
dance in FDCs compared to other gp38+CD31– stromal cells, we
initially attempted to isolate FDCs based on CR1 surface staining
but this approach was unsuccessful, perhaps due to the loss of
CR1 during tissue digestion. To overcome this obstacle, we
intercrossed CD21-Cre mice with Rosa26-ZsGreen mice. This
approach allowed fluorescence-activated cell sorting (FACS)
isolation of ZsGreenhigp38+CD31– stromal cells, and their FDC
identity was confirmed by very high CR1 expression (Figure 3F),
as well as high MFGE8 and lack of CD19 (data not shown).
Compared to FRCs, FDCs had significantly fewer CH25H tran-
scripts and slightly higher amounts of HSD3B7 (Figure 3F).
To further investigate CH25H, CYP7B1, and HSD3B7 expres-
sion in different lymphoid compartments, we stained splenic
tissue sections with anti-IgD to identify follicles and then isolated
different regions with laser-capture microscopy (Figure 3G) to
compare gene expression via real-time PCR. CH25H and
CYP7B1 were more abundant in the outer follicle and at the
B-T boundary as compared to the inner follicle (Figure 3H).
HSD3B7 was more abundant in the T zone than in B cell follicles
(Figure 3H). Because EBI2 transcriptional downregulation is
important for B cell positioning in GCs (Gatto et al., 2009; Pereira
et al., 2009), we immunized mice with sheep red blood cells
(SRBCs) and compared CH25H, CYP7B1, and HSD3B7 expres-
sion in the outer follicle, B-T boundary, and GCs. CH25H and
CYP7B1 expression were more than 10-fold higher in the outer
follicle and at the B-T boundary than within GCs (Figure 3I).munity 37, 535–548, September 21, 2012 ª2012 Elsevier Inc. 539
Figure 3. Differential CH25H, CYP7B1, and HSD3B7 Expression in Lymphoid Compartments
(A) Flow cytometric analysis of digested LN cells showing markers used to identify stromal cell populations. SSA, side scatter area.
(B and C) Quantitative RT-PCR analysis of total CD45+ and CD45– cells (B) and stromal cell subsets (C) for the indicated genes, relative to HPRT. Bars indicate
mean ± SEM of samples from three independent experiments.
(D) Bioassay of supernatant from sorted cells after overnight culture. Bars indicate mean ± SEM for triplicate wells. One experiment representative of three
experiments is shown.
(E) Quantitative RT-PCR analysis of CH25H transcript relative to HPRT. Data from 148 single-cell analyses are combined from two replicated experiments. Sorted
cells were gp38+CD31– FRCs identified as in (A). Venn diagram shows the number of cells positive for CXCL13, CCL21, and CR1-CR2 transcripts and the overlap
in their expression. A total of 16 of the 148 cells were negative for all three transcripts. Graph shows the relative expression of CH25H compared to HPRT in cells
positive for the indicated transcript. Lines indicate means, and dashed circles show the number of cells expressing high amounts of Ch25h.
(F) Quantitative RT-PCR analysis of CD21-Zsgreen positive or negative gp38+CD31– FRCs for the indicated genes relative to HPRT. Bars indicate mean ± SEM of
four samples from different experiments. SSC, side scatter.
(G–I) Analysis of CH25H, CYP7B1, and HSD3B7 mRNA expression in spleen by laser-capture microdissection and quantitative RT-PCR.
(G) A representative picture of different lymphoid compartments identified by anti-IgD staining, before and after laser capture.
(H and I) Quantitative RT-PCR analysis of CH25H, CYP7B1, and HSD3B7 mRNA in (H) unimmunized and (I) day 7 SRBC-immunized splenic tissues. Data in (H)
and (I) each show mean ± SEM for three independent capture experiments.
* represents p < 0.05; ** represents p < 0.01.
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CYP7B1 and HSD3B7 Establish EBI2 Ligand GradientsTaken together, these results suggest that at the tissue compart-
ment level, the biosynthetic capacity of 7a,25-OHC is highest in
outer follicular regions and at the B-T boundary and T zone,
whereas degradation capacity is greatest in the T zone.
Stromal Cells Are an Important 7a,25-OHC Source
for B Cell Positioning
For testing the stromal versus hematopoietic cell contribution to
the production of 7a,25-OHC and the establishment of EBI2
ligand gradients, a series of reciprocal BM chimeras were gener-
ated. We found that lack of BM-derived CH25H, CYP7B1, and
HSD3B7 did not change the EBI2 ligand activity detectable in
whole-spleen and LN tissue extracts (Figures 4A–4C and S3A).
Two days after HEL-OVA immunization, activated B cells posi-
tioned similarly at the inter- and outer follicle regardless of the540 Immunity 37, 535–548, September 21, 2012 ª2012 Elsevier Inc.presence of BM-derived CH25H, CYP7B1, or HSD3B7 (Fig-
ure S3C). CD169+ marginal metallophilic macrophages have
been speculated to be a potential EBI2 ligand source due to
their outer-follicle localization and the reported high expression
of CH25H by macrophages (Bauman et al., 2009; Diczfalusy
et al., 2009; Hannedouche et al., 2011; Liu et al., 2011; Park
and Scott, 2010; Zou et al., 2011). BM reconstitution replaces
most but not the entire population of host CD169+ macrophages
(Phan et al., 2009). In order to exclude possible effects of
residual host-derived CD169+ macrophages, we reconstituted
CD169DTR recipients (Miyake et al., 2007) with BM from
Ch25h/mice or littermate controls. Eight weeks after reconsti-
tution, we ablated residual host macrophages with diphtheria
toxin (DTx) treatment. The efficacy of the DTx treatment was
confirmed in control mice (data not shown and Muppidi et al.,
Figure 4. Stromal Cells, Rather Than BM-Derived Cells, Are an Important Source of 7a,25-OHC for B Cell Positioning
(A–C) Bioassay of titrated dilutions of splenic tissue extracts fromwild-type animals reconstituted with BM cells fromCh25h–/– (A),Cyp7b1–/– (B),Hsd3b7–/– (C), or
their littermate control mice (mean ± SEM, n = 4 mice, one experiment representative of two experiments).
(D and E) CD169DTR recipients were reconstituted with BM cells from Ch25h/ or wild-type mice and treated with 1 mg DTx 5–6 days before analysis.
(D) Splenic sections from the indicated mice transferred with MD4 B cells and OTII T cells and immunized with HEL-OVA 2 days before analysis. One experiment
representative of at least three experiments is shown.
(E) Quantitative RT-PCR analysis of CH25H mRNA (mean ± SEM, n = 3 experiments) in laser-capture microdissected SRBC-immunized GC-containing splenic
tissues.
(F–H) Bioassay of titrated dilutions of splenic tissue extracts fromCh25h–/– (F),Cyp7b1–/– (G),Hsd3b7–/– (H), or their littermate controlmice reconstitutedwithwild-
type BM cells (mean ± SEM, n = 4 mice).
(I) Splenic sections from the indicated mice that received MD4 B cells and OTII T cells and then were immunized with HEL-OVA 2 days before analysis. One
experiment representative of at least three replicated experiments is shown. WT, wild-type.
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CYP7B1 and HSD3B7 Establish EBI2 Ligand Gradients2011). Activated B cells localized similarly to outer follicular
regions in DTx-treated CD169DTR mice that had been reconsti-
tuted withCh25h–/– orCh25h+/+ BM cells (Figure 4D). In addition,
CD169DTR recipients reconstituted with Ch25h–/– BM and
treated with DTx were immunized with SRBC and compared
for CH25H expression in the outer follicle and in GCs by laser-
capture microdissection. CH25H messenger RNA (mRNA) re-
mained more abundant in the outer follicle and at the B-T
boundary compared to the GCs (Figure 4E). Taken together,
these findings suggest that BM-derived cells are not major
contributors to lymphoid tissue EBI2 ligand generation under
conditions of homeostasis or during the early phases of the
T cell-dependent antibody response.
In reciprocal experiments, we reconstituted each type of
enzyme-deficient mouse strain or their littermate controls with
wild-type BM. Reconstitution with wild-type hematopoietic cells
failed to restore EBI2 ligand activity in Ch25h–/– and Cyp7b1–/–
recipients to amounts detected in the littermate control mice,
although some ligand was generated (80% reduced; Figures
4F, 4G, and S3B). Moreover, EBI2 ligand remained elevated in
Hsd3b7 –/– recipients reconstituted with wild-type BM-derived
cells, although the 2–3-fold overproduction was less than
the 10-fold overproduction observed in complete Hsd3b7 –/–
mice (compare Figures 4H and 2F). These results indicate that
stromal cells are major cellular sources and sinks for EBI2 ligand
in lymphoid organs, and BM-derived cells contribute to a lesser
extent.
We next investigated whether stromal cell enzyme defi-
ciencies affected B cell positioning. In Ch25h–/–, Cyp7b1–/–,
and Hsd3b7–/– mice that had been reconstituted with wild-type
BM cells, day-2-activated B cells failed to accumulate in outer
follicles and instead distributed evenly throughout the follicle
(Figure 4I). Moreover, EBI2-dependent segregation of naive
B cells between inner and outer follicles of spleen, LNs, and
Peyer’s patches was disrupted in Ch25h–/–, Cyp7b1–/–, and
Hsd3b7 –/– mice reconstituted with mixtures of wild-type
and Ebi2–/– BM (Figure S3D). Taken together, these results
support the above interpretation that stromal cells are the main
sources and catabolic sites of the 7a,25-OHC needed to guide
B cells to interfollicular and outer follicular regions.
HSD3B7 Acts Intrinsically in DCs to Restrict EBI2 Ligand
Generation
In addition to guiding B cells to interfollicular and outer follicular
regions 2 days after T cell-dependent activation, EBI2 is involved
in localizing activated B cells prior to T cell interaction. In the
absence of EBI2, 6–10 hr after antigen encounter, B cells cluster
near the center of the follicle-T zone interface rather than distrib-
uting along its length and sometimes extend into the T zone itself
(Kelly et al., 2011). Similar to Ebi2–/– B cells, 10-hr-antigen-acti-
vated wild-type B cells failed to distribute evenly along the B-T
boundary in CH25H-, CYP7B1-, and HSD3B7-deficient mice
and instead tended to cluster at the center of the boundary,
with some cells entering more deeply into the T zone (Figure 5A).
These data are consistent with EBI2 ligand abundance normally
being greater at the tips of the interface, near interfollicular
regions, than at the center of the interface. Given that CCR7
ligands are thought to be rather uniformly distributed along the
interface (Okada et al., 2005), the factors causing cells to favor542 Immunity 37, 535–548, September 21, 2012 ª2012 Elsevier Inc.the central location are not yet clear. We next examined whether
lack of CH25H, CYP7B1, or HSD3B7 in BM-derived cells
affected early activated B cell positioning along the B-T
boundary. Lack of CH25H or CYP7B1 in BM-derived cells did
not affect B cell positioning along the boundary (Figure S4A);
however, lack of HSD3B7 in BM-derived cells resulted in an
increase in the extent of activated B cell positioning into the T
zone (Figures 5B, 5C, and S4B). In this case, the cells did not
extend in preferentially from the center of the B-T zone interface
but gained more variable access, sometimes appearing to
spread into the T zone along the length of the interface. The
attraction of activated B cells into the T zone was EBI2-depen-
dent, in that Ebi2 –/– MD4 B cells clustered at the center of
the B-T interface similarly in Hsd3b7 –/– and control chimeras
(Figures 5B, 5C and S4C). Total splenic DCs expressed many
more Hsd3b7 transcripts than T or B cells (Figure 2A), and this
expression in turn restrained DC production of EBI2 ligand, as
Hsd3b7/ splenic DCs produced 5-fold more EBI2 ligand
in vitro than wild-type splenic DCs (Figure 5D). The three major
splenic DC subsets all expressed HSD3B7, though expression
in CD8+ DCs was 3-fold higher than in the other subsets (Fig-
ure 5E). They also expressed detectable CH25H and CYP7B1,
the latter enzyme also being most abundant in CD8+ DCs (Fig-
ure 5E). Culture supernatants from the sorted Hsd3b7 –/– DCs
showed that each subset made more EBI2 ligand than its wild-
type counterpart, with Hsd3b7 –/– CD8+ DCs generating several
fold more ligand than the other subsets (Figures 5F and S4D).
Finally, EBI2 surface expression on CD4+ T cells from chimeric
mice lacking HSD3B7 in hematopoietic cells was reduced
compared to the amounts on T cells from control BM chimeras,
though not to the extent seen in Hsd3b7 –/– mice (Figure 5G).
Taken together, these results suggest that HSD3B7 activity in
DCs, particularly CD8+ DCs, restrains their production of EBI2
ligand and, in so doing, helps maintain the central T zone as
a low-EBI2-ligand environment. However, our findings do not
exclude an EBI2-ligand-metabolizing role for HSD3B7 in other
hematopoietic cell types.
FDCs Are Required for EBI2-Dependent B Cell
Segregation in the Follicle
The above findings established that 7a,25-OHC biosynthetic
enzyme levels were low in the follicle center and that CH25H
transcript amounts were lower in FDCs compared to the majority
of other lymphoid stromal cells. We recently found that when
FDCs are ablated, markers of T zone stromal cells become
increased inside the B cell area (Wang et al., 2011). To test
whether FDCs are required to maintain EBI2 ligand gradients
within the follicle, Cd21-cre+ /RosaDTR or RosaDTR control mice
were reconstituted with Ighb Ebi2–/– BM and Igha Ebi2+/+ BM
cells and treated with DTx 2 days prior to analysis (Figure 6A).
FDC ablation was confirmed by the loss of CD35 (CR1) staining
at the follicle center (Figure 6B). Following FDC ablation, ER-
TR7+ FRCswere found in increased abundance within the center
of B cell areas (Figure 6B) as previously observed (Wang et al.,
2011). After FDC ablation, the segregation of naive wild-type
and EBI2-knockout B cells between the outer and inner follicle,
respectively, disappeared in all lymphoid tissues examined
(Figures 6C and S5). FDC ablation did not affect activated
B cell positioning along the B-T boundary 10 hr after HEL
Figure 5. Hematopoietic Cells Help Main-
tain the T Zone as a Low-EBI2-Ligand Envi-
ronment
(A) Splenic sections from the indicated mice that
had received wild-type MD4 B cells, 10 hr after
HEL immunization.
(B) Splenic sections from wild-type mice recon-
stituted with Hsd3b7–/– or wild-type BM that
received wild-type MD4 cells or Ebi2–/– MD4 cells
the day before andwere immunized with HEL 10 hr
before analysis. One representative picture of
four replicated experiments.
(C) Fraction of MD4 cells in T zone, center of B-T
cell interface, and interfollicular interface in the
indicated mice. The center was determined as the
middle 50% of the B-T interface. The width of
the interface is defined as 25% of the follicle
diameter. Bars indicate mean ± SEM; n = 15–20
individual follicles from four to six different exper-
iments.
(D) Bioassay of culture supernatants from FACS-
sorted Hsd3b7–/– or wild-type splenic CD11chi
MHCII+ DCs (mean ± SEM, n = 3 independent
experiments).
(E) Quantitative PCR analysis of CH25H, CYP7B1,
and HSD3B7 transcript abundance in the sorted
DC subpopulations, relative to HPRT (mean ±
SEM, n = 4 independent experiments).
(F) Bioassay of culture supernatants from DC
subpopulations in Hsd3b7–/– mice (mean ± SEM,
n = 3 different sorting samples).
(G) EBI2 surface expression on splenic CD4+
T cells from WT recipients reconstituted with
Hsd3b7–/– or Hsd3b7+/+ BM or from a Hsd3b7–/–
mouse. Cells from an Ebi2–/– mouse are included
as a staining control. One experiment represen-
tative of five pairs of chimeric mice is shown.
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CYP7B1 and HSD3B7 Establish EBI2 Ligand Gradientsimmunization (Figure 6D), but it prevented activated B cells from
preferentially localizing at interfollicular and outer follicular
regions 48 hr after HEL-OVA immunization (Figure 6D). More-
over, the differential in CH25H expression between the inner
and outer regions of the IgD+ B cell area within splenic white-
pulp cords was no longer evident (Figure 6E). Taken together,
these results indicate that FDCs are required for maintaining
the center of the B cell area as a region with low EBI2 ligand
biosynthetic capability, and they support the conclusion thatImmunity 37, 535–548, Sethis property mediates the EBI2-depend-
ent segregation of B cells between the
inner and outer follicle.
CYP7B1, CH25H, and HSD3B7 Are
Required for Mounting Plasma Cell
Responses
To test the importance of CYP7B1-medi-
ated generation of 7a,25-OHC for mount-
ing antibody responses, we adoptively
transferred GFP-transgenic HEL-specific
Hy10 B cells into wild-type recipients
and immunized the mice with SRBC con-
jugated with mutated low-affinity HEL2x
(Paus et al., 2006). We found thatantigen-specific Hy10 B cells were less abundant in Cyp7b1–/–
compared with Cyp7b1+/– mice at day 5 (Figures 7A and 7B).
The percentage and number of IgM, IgG1, and IgG2b plasma
cells were markedly reduced in Cyp7b1–/– mice (Figures 7A and
7B). Similar reductions in total HEL-specific B cells and IgM,
IgG1, and IgG2b plasma cells were observed when Hy10 B cells
were transferred toCh25h–/– recipients (Figure 7C), extending the
previous finding of a reduced total plasma cell response to
SRBCs in Ch25h–/– mice (Hannedouche et al., 2011). In order toptember 21, 2012 ª2012 Elsevier Inc. 543
Figure 6. FDCs Establish a Low-EBI2-
Ligand Environment in the Follicle Interior
(A and B) ROSADTR+CD21-Cre+ mice that express
the DTR in CD21+ cells or ROSADTR+CD21-Cre–
control mice were reconstituted with wild-type
BM, and the chimeric mice (CD21-DTR or control
chimeras) were DTx treated and analyzed 2 days
later.
(A) Experimental scheme.
(B) Representative splenic sections with IgD
(brown) and CD35, Collagen IV, or ER-TR7 (blue)
staining. Dashed black lines indicate B-T zone
boundary, determined based on IgD stain.
(C) CD21-DTR chimeras containing Igha (WT) and
Ighb (Ebi2–/–) B cells were DTx treated 2 days
before analysis of spleen, LN, and Peyer’s patch
sections.
(D) Splenic section of DTx-treated CD21-DTR
chimeras, 10 hr after HEL (left panel) or 2 days
after HEL-OVA (right panel) immunization. One
experiment representative of three replicated
experiments is shown.
(E) Analysis of CH25H mRNA expression in spleen
tissue from FDC-ablated or control mice by laser-
capture microdissection and quantitative RT-
PCR. Data show the mean of two different capture
experiments and are representative of two addi-
tional experiments. B-T, B-T boundary.
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CYP7B1 and HSD3B7 Establish EBI2 Ligand Gradientsdetermine whether the diminished responses were due to the
loss of EBI2 ligand, we asked whether EBI2-deficient cells
showed any difference in responsiveness in wild-type versus
enzyme-deficient hosts. Mixtures of Ebi2+/+ (CD45.1+CD45.2+,
20%) and Ebi2–/– (CD45.2+, 80%) Hy10 B cells were trans-
ferred into Cyp7b1+/– and Cyp7b1–/– recipients, and the mice
were immunized with SRBC-HEL2x. In the control hosts, the544 Immunity 37, 535–548, September 21, 2012 ª2012 Elsevier Inc.Ebi2–/– Hy10 B cells showed a 50%–80%
reduction in the plasma cell response
compared to the cotransferred Ebi2+/+
Hy10 B cells (Figures 7D and 7E), adding
to the evidence that EBI2 has a B cell-
intrinsic role in supporting plasma cell re-
sponses (Gatto et al., 2009). Importantly,
however, the response of Ebi2–/– and
Ebi2+/+ Hy10 B cells was similarly low in
Cyp7b1–/– hosts, indicating that the posi-
tive influence of EBI2 on the plasma cell
response was lost when the host lacked
Cyp7b1. Very similar findings were made
in Ch25h–/– hosts and in Hsd3b7 –/– hosts
(Figures 7F and 7G). These results indi-
cate that CYP7B1, CH25H, and HSD3B7
are all required for EBI2-dependent early
B cell accumulation and plasma cell
response following immunization with a
T cell-dependent antigen.
DISCUSSION
CYP7B1 and HSD3B7 are best defined
for their roles in bile acid synthesis in theliver (Russell, 2003). Our studies show that these two enzymes,
together with CH25H, are required in lymphoid organs for the
generation of EBI2 ligand gradients that guide the movements
of naive and activated B cells. We have established that
HSD3B7-mediated modification of 7a,25-OHC inactivates EBI2
ligand activity. We demonstrated that CH25H, CYP7B1, and
HSD3B7 constitute a metabolic pathway that is required in
Figure 7. Lack of CYP7B1, CH25H, and HSD3B7 Results in Diminished Plasma Cell Responses
(A) Plasma cell response in Cyp7b1–/– or littermate control mice receiving Hy10 cells at day 5 after immunization with SRBCs conjugated with HEL2x. Percentage
of HEL-binding Hy10 B cells, HEL-bindinghiCD138hi plasma cells (PCs) and HEL-bindinghiFas+GL7+ GC cells among total splenocytes are shown asmean ± SEM
(n = 5 mice).
(B and C) Numbers of HEL-binding B cells, total plasma cells, and plasma cells in different Ig isotypes (mean ± SEM, n = 5 mice) in Cyp7b1–/– (B), Ch25h–/– (C), or
littermate control mice.
(D–G) Plasma cell response in Cyp7b1–/–, Ch25h–/–, Hsd3b7–/–, or littermate control mice that received mixed Ebi2–/– Hy10 (CD45.1+) and wild-type Hy10
(CD45.1+CD45.2+) cells and were immunized with SRBCs conjugated with HEL2x.
(D) Representative plasma cell gates of Cyp7b1–/– or littermate control recipients.
(E–G) Percentage of plasma cells in Cyp7b1–/– (E), Ch25h–/– (F), Hsd3b7–/– (G), or littermate control mice (mean ± SEM, n = 4–8 mice).
* represents p < 0.05; ** represents p < 0.01.
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CYP7B1 and HSD3B7 Establish EBI2 Ligand Gradientslymphoid stromal cells for establishing B cell-guiding 7a,25-OHC
gradients. We also have provided evidence that FDCs are
needed to maintain a low-EBI2-ligand zone in the follicle interior
and that HSD3B7 restricts EBI2 ligandproduction by T zoneDCs.ImWe propose the following model for how B cell-guiding
EBI2 ligand gradients are established in lymphoid tissues.
CH25H and CYP7B1 are needed in radiation-resistant stromal
cells, are abundantly expressed and active in CXCL13+ andmunity 37, 535–548, September 21, 2012 ª2012 Elsevier Inc. 545
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CYP7B1 and HSD3B7 Establish EBI2 Ligand GradientsCCL21+ FRCs, but not lymphocytes, and are poorly expressed in
the inner follicle compared to surrounding regions. This enzyme
distribution results inmore ligand production at the follicle perim-
eter than at the follicle center, accounting for the propensity of
EBI2hi cells to be attracted to the follicle perimeter (Gatto et al.,
2011; Kelly et al., 2011; Pereira et al., 2009). HSD3B7, by
contrast, is present in similar amounts in the inner follicle and
at the perimeter, and thus we propose that by shortening the
7a,25-OHC half-life, this enzyme ensures that the concentration
of ligand closely mirrors the distribution of the biosynthetic
enzymes. CYP7B1 and CH25H are also abundant in the T
zone, but in this compartment HSD3B7 is highly expressed,
causing T zone 7a,25-OHC to be relatively low. As a result, ligand
concentrations are most likely higher along the follicle-T zone
interface than within the T zone proper. In the first hours after
B cell activation, CCR7 and EBI2 are both upregulated, and B
cells move to the T zone in a CCR7-dependent manner (Gatto
et al., 2009; Kelly et al., 2011; Pereira et al., 2009; Reif et al.,
2002); however, their propensity to remain at and distribute
along the length of the B-T zone interface is promoted by the
abundance of EBI2 ligand in this region. Later, after activation
(day 2), when B cells have received T cell help, they maintain
high EBI2 function (Figure 1) and CXCR5 expression but down-
regulate CCR7 function (Chan et al., 2009; Coffey et al., 2009;
Kelly et al., 2011). As a result, these cells are less strongly at-
tracted to the B-T zone interface and relocate to the outer follicle
in an EBI2-dependent manner. A recent study suggested EBI2
transmits proproliferative signals to B cells (Benned-Jensen
et al., 2011). We have not found 7a,25-OHC to have mitogenic
effects on B cells (T.Y., L.M.K., and J.G.C., unpublished data).
Our findings of similar B cell positioning and antibody response
defects in mice that are unable to make 7a,25-OHC (CH25H-
and CYP7B1-deficient) and in mice that have an elevated abun-
dance of 7a,25-OHC (HSD3B7-deficient) are most consistent
with B cell EBI2 functioning principally as a guidance receptor.
More abundant CH25H and CYP7B1 expression in the outer
versus inner follicle highlights the specialization of follicular
stromal cells in these regions. One subset of stromal cells situ-
ated immediately beneath the marginal and subcapsular sinuses
is the MRC (Katakai et al., 2008). Although there is currently no
method available for isolating these cells, the abundance of the
MRC marker TRANCE in our FRC preparations confirms the
presence of these cells and is consistent with the possibility
that they are a source of CH25H and CYP7B1. We attempted
to further test whether CH25Hwas enriched in TRANCE+ stromal
cells using single-cell PCR but found the detection of TRANCE
via this procedure to be variable. We had similar difficulties
with reproducible detection of CYP7B1 in the single-cell anal-
ysis. However, the single-cell approach did allow us to demon-
strate lower expression of CH25H by CR1-CR2hi cells than by
the majority of CXCL13+ FRCs, in agreement with the findings
for flow-cytometry-purified FDCs. These data are in accord
with the laser-capture microscopy analysis results, suggesting
that the stromal cells at the follicle center manifest only low
amounts of CH25H. We propose that the loss of EBI2 gradient
information following FDC ablation occurs because of the role
of FDCs in repressing FRCs within follicles. The rapid invasion
or induction of follicular FRCs following FDC ablation leads to
a more uniform expression of CH25H and CYP7B1 throughout546 Immunity 37, 535–548, September 21, 2012 ª2012 Elsevier Inc.the B cell area, and this probably causes the loss of a gradient
in 7a,25-OHC biosynthetic activity. FDCs are lymphotoxin
dependent, and the loss of EBI2-guided B cell segregation in
follicles following lymphotoxin blockade (Pereira et al., 2009) is
also consistent with this model of EBI2 ligand maintenance by
FDCs. Although FDCs express CXCL13, a finding confirmed
here in the single-cell PCR analysis, their ablation does not
cause a reduction in CXCL13 abundance in the follicle (Wang
et al., 2011). Moreover, EBI2-dependent segregation remains
in Cxcl13–/– recipients (Pereira et al., 2009), and we have not
observed marked differences in Cxcl13 mRNA or protein
between the inner and outer follicle (Cyster et al., 2000; Wang
et al., 2011), making it unlikely that the loss of EBI2-dependent
B cell segregation following FDC-ablation is due to altered
CXCL13 distribution.
Previous in vitro and in vivo studies have shown the potent
ability of toll-like receptor (TLR) ligands and type I interferon
(IFN) signaling to induce CH25H in macrophages and DCs
following exposure to innate immune stimuli (Bauman et al.,
2009; Diczfalusy et al., 2009; Park and Scott, 2010; Zou et al.,
2011). Althoughwe have established the essential role of stromal
cells in producing and degrading EBI2 ligand in lymphoid organs
to support B cell migration responses, we do not exclude the
possibility that macrophages (such as marginal metallophilic or
subcapsular sinus macrophages) become involved in ligand
production under some inflammatory conditions.
Our findings suggest that DC production of 7a,25-OHC is nor-
mally restricted by intrinsic HSD3B7-mediated degradation. It is
notable that CD8+ DCs expressed moreHsd3b7 transcripts than
did CD8– DCs. Within the spleen, CD8+ DCs (that coexpress
DEC205) are abundant in the inner T zone, whereas CD8– DCs
are abundant in the major interfollicular regions (Steinman
et al., 1997). Our studies are consistent with the possibility that
this difference in HSD3B7 expression contributes to the central
T zone’s status as a low-EBI2-ligand zone compared to interfol-
licular regions. Indeed, it can be speculated that EBI2 favors
encounters between B cells and CD8– DCs by promoting move-
ment to interfollicular regions. We anticipate that under activa-
tion conditions leading to CH25H induction (Bauman et al.,
2009; Diczfalusy et al., 2009; Park and Scott, 2010; Zou et al.,
2011), DC production of 7a,25-OHC exceeds HSD3B7-medi-
ated degradation and acts to promote new interactions between
DCs and EBI2-expressing cells. Although HSD3B7 transcripts
were 10-fold more abundant in DCs than in lymphocytes, our
studies do not exclude roles for hematopoietic cells other than
DCs in mediating 7a,25-OHC metabolism in the T zone.
CYP7B1 deficiency causes a loss of detectable EBI2 ligand
production in lymphoid organs, consistent with this being the
only enzyme known to catalyze 7a-hydroxylation of 25-OHC
(Russell, 2003) and with the finding of reduced 7a,25-OHC in
spleens of clotramizole-treated mice (Liu et al., 2011). CYP7B1
will 7a-hydroxylate 27-hydroxycholesterol to produce 7a,27-
OHC, another EBI2 ligand that is about one-tenth as potent as
7a,25-OHC in migration assays (Hannedouche et al., 2011; Liu
et al., 2011). The loss of EBI2 ligand function in CH25H-deficient
mice, animals that fully retain the ability to synthesize 27-OHC
and 7a,27-OHC, argues against a major role for 7a,27-OHC in
guiding the movement of B cells in lymphoid tissues. It remains
possible that 7a,27-OHC functions to control a cellular behavior
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CYP7B1 and HSD3B7 Establish EBI2 Ligand Gradientsnot studied here. Moreover, because both 7a,25-OHC and
7a,27-OHC are substrates for HSD3B7 (Russell, 2003), it is pos-
sible that some of the increase in EBI2 ligand detectable in the
absence of this enzyme is attributable to 7a,27-OHC. Additional
studies will be needed to quantify 7a,25-OHC and 7a,27-OHC
concentrations in mouse lymphoid and peripheral tissues.
Although compromised in EBI2 ligand production, CYP7B1-
deficient mice have elevated circulating 25-OHC and 27-OHC
(Bauman et al., 2009; Li-Hawkins et al., 2000). These oxysterols
have the capacity to modulate some immune cell functions
through actions on nuclear hormone receptors (Bensinger
et al., 2008; Kalaany and Mangelsdorf, 2006; Villablanca et al.,
2010) and to regulate IgA production (Bauman et al., 2009).
Increases in these oxysterols are unlikely to account for the
defective IgM and IgG plasma cell responses we describe
here, because EBI2-deficient B cells are equally compromised
in the generation of plasma cells in both wild-type and
CYP7B1-deficient hosts. That is, the positive influence of
CYP7B1 in promoting IgM and IgG plasma cell responses
appears to depend upon the generation of EBI2 ligand and
signaling via EBI2. Moreover, in contrast to the altered mucosal
IgA responses seen in CH25H- and CYP7B1-deficient mice
(Bauman et al., 2009), we have not detected altered IgA produc-
tion in EBI2-deficient mice (A. Reboldi, L.M.K., and J.G.C.,
unpublished data). Further supporting the conclusion that it is
the amount of EBI2 ligand that is important is the discovery of
similar defects in the plasma cell response in Ch25h/ and
Hsd3b7/ mice. An important challenge for future studies will
be elucidating whether EBI2, CH25H, CYP7B1, and HSD3B7
support B cell responses by promoting more efficient interac-
tions between B and T cells at the B-T boundary and in interfol-
licular regions, or by promoting interactions between early
plasmablasts and factors in interfollicular and outer follicular
regions that support their growth and differentiation.EXPERIMENTAL PROCEDURES
Mice
C57BL/6NCr and C57BL/6-cBrd/cBrd/Cr (CD45.1) mice with ages of
7–9 weeks were from the National Cancer Institute (Frederick, MD, USA).
B6.Cg-IghaThy1aGp1a/J mice, B6-Gt (ROSA)26Sortm1(HBEGF)Awai (Rosa-DTR)
mice, B6.Cg-Gt(ROSA)26Sortm6(CAG-Zsgreen1)Hze/J mice, and GFP-trans-
genic mice (Tg(UBC-GFP)30Scha/J) were from the Jackson Laboratory.
Ebi2/ mice (Pereira et al., 2009) were backcrossed to C57BL/6J for 11
generations. These mice carry an eGfp gene inserted in place of the Ebi2
open reading frame. Ch25h/ mice (Bauman et al., 2009) were backcrossed
ten generations to C57BL/6; Cyp7b1/ mice were of one of two strains (Li-
Hawkins et al., 2000; Rose et al., 2001) and backcrossed to C57BL/6J for
five generations. Hsd3b7/ mice were backcrossed to C57BL6/J for two
generations and maintained on chow containing 0.5% cholic acid and pan-
vitamin-supplemented water (Shea et al., 2007). CD169DTR mice (Miyake
et al., 2007), B6.Tg(Cr2-Cre)3Cgn (CD21-cre) mice, HEL-specific MD4 Ig-
transgenic and Hy10 mice, and OVA-specific OTII TCR-transgenic mice
were on a C57BL/6J background. Animals were housed in a specific path-
ogen-free environment in the Laboratory Animal Resource Center at the
University of California, San Francisco, and all experiments conformed to
ethical principles and guidelines approved by the Institutional Animal Care
and Use Committee.
Cell Adoptive Transfer and Immunizations
For visualization of in situ B cell position at day 2 of the T cell-dependent
response, mice were adoptively transferred with 1–10 3 106 wild-type orImEbi2/ MD4 splenocytes and 1–5 3 106 wild-type OTII splenocytes. One
day after cell transfer, recipients were immunized intraperitoneally (i.p.) with
50 mg HEL-OVA conjugate in RIBI-based Sigma adjuvant system. To examine
activated B cell distribution at 10 hr after antigen exposure, mice were given
107 MD4 splenocytes the day before and were injected i.p. with 5 mg HEL in
the absence of adjuvant. For antibody responses, 1 3 105 Hy10 B cells were
adoptively transferred into Cyp7b1/, Ch25h/, Hsd3b7/, or littermate
Cyp7b1+/ recipients. One day after cell transfer, recipients were i.p. immu-
nized with 2 3 108 SRBCs conjugated with low-affinity HEL2x as described
(Gatto et al., 2009).
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